Rankings
▼
Calendar
TIL FY 2019 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena
TIL
Instil Bio, Inc.
$60M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$20,000
Operating Income
-$7M
Net Income
-$6M
EPS (Diluted)
$-1.01
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$293,000
Balance Sheet
Total Assets
$9M
Total Liabilities
$1M
Stockholders' Equity
$8M
Cash & Equivalents
$9M
← Q1 2020
All Quarters
